Alzheimer Dementia
Conditions
Keywords
Alzheimer Dementia, AD, patients, cognitive
Brief summary
Examine the construct validity, the group discriminant ability, and the inter-rater reliability of a novel dementia rating scale (QuQu scale: QUick QUestion scale) candidate for the evaluation of patients with Alzheimer Dementia (AD)
Interventions
OTHERStandard therapy of Alzheimer Dementia (AD)
OTHERObservation
Sponsors
Daiichi Sankyo Co., Ltd.
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Study design
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
1. Alzheimer Dementia (AD) patients and patients with cognitive concern without dementia 2. Written Informed consent by each subject and/or a legal representative, and study informant. If the doctor decides that the patient has no trouble in understanding this study, the written informed consent of a legal representative may be exempted. If not, this study needs a written informed consent by a legal representative and the patient except the case where the consent is hardly obtained due to the progression of the disease.
Exclusion criteria
1. patients with other types of dementia (e.g. vascular dementia, Levy body dementia, frontotemporal dementia) 2. patients with other diseases which cause secondary dementia prior to Alzheimer Dementia (AD) 3. patients with other severe neurological disease or psychiatric disorder without Alzheimer Dementia (AD) 4. patients with other medical conditions where the investigators determine that it is inappropriate for the subject of this study (e.g. inappropriate for the evaluation of dementia rating scale)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Novel Dementia Rating Scale (QUick QUestion Scale) | 1 day |
Countries
Japan
Outcome results
None listed